颈动脉分流套件市场报告：2031 年趋势、预测与竞争分析

全球颈动脉分流术套件市场的未来前景预计将源于医院和门诊手术中心市场的机会。预计在2025-2031年的预测期内，全球颈动脉分流术套件市场的复合年增长率将达到11.7%。该市场的主要驱动因素包括颈动脉疾病盛行率的上升、人们对中风预防意识的增强以及外科技术的不断进步。

• 根据类型，Lucintel 预测传统分流器在预测期内将经历高速成长。
• 从应用来看，医院预计将经历高速成长。
• 根据地区，预计北美将在预测期内实现最高成长。

颈动脉分流套件市场的新趋势

颈动脉分流套件市场受到各种新兴趋势的推动，这些趋势正在塑造市场格局并决定新产品和新策略。

• 微创手术：微创技术已成为颈动脉分流套件市场的核心趋势之一。这些手术具有切口小、恢復时间短、併发症少等优点。因此，越来越多的医疗保健提供者选择支援此类手术的分流套件。患者受益于更快的康復和更低的风险，而医生则可以改善手术效果。这些发展增加了对专用设备的需求，以迎合微创手术的趋势。
• 技术创新：分流套件的技术进步，例如即时追踪和精准度提升，正在彻底改变市场。先进材料和技术（例如生物可吸收分流器和血流监测感测器）的使用正在提高手术的成功率。这些技术旨在提高患者安全性并降低併发症风险。随着技术的进步，市场上出现了更多先进的设备，这些设备不仅可以提高手术效率，还可以改善患者的治疗效果，从而推动整个市场的发展。
• 人口老化：人口老化，尤其是在美国、日本和德国等已开发国家，是颈动脉分流套件市场成长的主要驱动力之一。老年患者由于心血管疾病风险较高，且更有可能需要进行颈动脉手术。由于医疗保健系统需要更多的手术，这个年龄层的患者群体对成功的分流套件的需求不断增长。未来几年，人口趋势可能会继续推动市场发展。
• 迈向个人化医疗：颈动脉分流套件产业正经历着向个人化医疗的转变，即根据每位患者的具体需求量身定制治疗方法和设备。个人化分流套件，即根据患者独特的解剖结构差异而设计的套件，正变得越来越普遍。这种个人化解决方案有助于最大限度地减少併发症，并管理患者的特殊情况，从而获得更好的手术效果。影像技术和患者特定资讯的发展也为个人化医疗提供了补充，使医疗专业人员能够在手术室中做出更明智的决策，并改进治疗方案。
• 不断变化的法规和核准：不断变化的法规正在塑造颈动脉分流套件市场。某些市场（例如美国和欧洲）已经收紧了法规，以确保只有最安全、最高效的设备才能获准使用。相反，中国和印度等市场则迅速获得了监管部门的核准，并加速了发展。不断变化的法规要求企业遵守全球标准，从而推动创新并提高颈动脉分流套件的整体品质和安全性。

这些新兴趋势——微创治疗、技术进步、人口老化、个人化医疗和监管变化——正在改变颈动脉分流套件市场，随着持续的技术创新不断改善患者照护、手术结果和整体市场成长，使其更加充满活力。

颈动脉分流套件市场的最新趋势

颈动脉分流术套件市场目前的趋势表明，人们越来越重视提高颈动脉手术的有效性和安全性。技术进步和监管变革正在推动先进医疗设备在各个地区的广泛应用。

• 先进分流套件的推出：近期趋势推动了采用优质材料和设计的分流套件的开发，从而最大限度地降低了併发症的风险。分流套件改善了血流调节，耐受性更强，从而改善了手术效果并缩短了患者康復时间。生物可吸收材料的使用和改进的分流结构显着降低了感染和血栓栓塞併发症的风险。
• 新兴市场的成长：受医疗成本上涨和心血管疾病盛行率上升的推动，颈动脉分流套件市场在中国和印度等新兴国家正以惊人的速度成长。各大公司纷纷进入这些国家，为当地市场提供价格更低、性能更佳的设备。这些国家的成长意味着巨大的机会，可以触及先前服务不足的患者群体。
• 先进的病患监测功能：新型颈动脉分流套件越来越多地配备即时监测技术。这些技术进步有助于医护人员在手术过程中监测血液循环，降低併发症发生率并提高手术精准度。这些套件整合了感测器和其他监测系统，还能帮助外科医生在手术过程中即时进行必要的调整，从而提高病患安全性。
• 微创手术增加：分流套件技术的进步显着增加了微创颈动脉手术的数量。这些手术具有恢復更快、併发症更少、整体疗效更佳等优点。这导致对用于这些手术的分流套件的需求增加，从而推动了进一步的产品开发。
• 监管变化与核准：世界各地的监管机构正在简化新型颈动脉分流套件的核准程序。这项变化正在加快复杂产品的上市时间。各公司正与监管机构密切合作，以遵守各国法规，加速产品上市速度并提高设备安全性。

颈动脉分流套件行业的当前趋势表明，该行业正致力于提高安全性、最大限度地减少併发症，并拓展新的市场覆盖范围。这些趋势正在彻底改变市场，并透过技术进步推动成长，尤其是在新兴经济体。

目录

第一章执行摘要

第二章全球颈动脉分流套件市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章 2019年至2031年市场趋势及预测分析

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球颈动脉分流套件市场趋势（2019-2024 年）及预测（2025-2031 年）
• 全球颈动脉分流套件市场类型
  • 常规分流器
  • 逆流系统
• 全球颈动脉分流套件市场（按应用）
  • 医院
  • 门诊手术中心
  • 其他的

第四章2019年至2031年区域市场趋势与预测分析

• 颈动脉分流套件市场（按地区）
• 北美颈动脉分流套件市场
• 欧洲颈动脉分流套件市场
• 亚太颈动脉分流套件市场
• 世界其他地区的颈动脉分流套件市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球颈动脉分流套件市场成长机会（按类型）
  • 全球颈动脉分流套件市场成长机会（按应用）
  • 区域颈动脉分流套件市场的成长机会
• 全球颈动脉分流套件市场的新趋势
• 战略分析
  • 新产品开发
  • 全球颈动脉分流套件市场产能扩张
  • 全球颈动脉分流套件市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业简介

• Cardinal Health
• LeMaitre
• McKesson Medical
• Edwards Lifesciences Corporation
• Axiom Medical Supplies

The future of the global carotid artery shunt kit market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global carotid artery shunt kit market is expected to grow with a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of carotid artery diseases, the growing awareness of stroke prevention, and the increasing advancements in surgical techniques.

• Lucintel forecasts that, within the type category, conventional shunt is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness higher growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the Carotid Artery Shunt Kit Market

The carotid artery shunt kit market is driven by a mix of emerging trends. These emerging trends are shaping the landscape of the market and determining new products and strategies.

• Minimally Invasive Procedures: Minimally invasive methods have emerged as one of the core trends in the carotid artery shunt kit market. These procedures have benefits such as smaller incisions, quicker recovery times, and fewer complications. Therefore, healthcare providers are increasingly choosing shunt kits that support such techniques. Patients profit from faster recoveries and fewer risks, while doctors can enhance their outcomes in surgery. This development is fueling the need for specialty devices that respond to the increasing trend toward less invasive intervention.
• Technological Innovations: Technological advancements in shunt kits, including real-time tracking and improved accuracy, are revolutionizing the market. The use of advanced materials and technologies, including bioresorbable shunts and blood flow monitoring sensors, is enhancing the success of surgeries. These technologies are designed to enhance patient safety and reduce the risk of complications. With advancements in technology, the market is witnessing more advanced devices which not only improve surgical proficiency but also patient results, resulting in the overall development of the market.
• Aging Population: Aging population, especially in developed nations like the U.S., Japan, and Germany, is one of the main drivers for the growth of the carotid artery shunt kit market. Elderly patients are at a higher risk for cardiovascular disease and thus will more likely need carotid artery procedures. This age group is contributing to the growing demand for successful shunt kits as health systems become increasingly needed for operations. The demographic trend will keep the market in motion over the next few years.
• Move Toward Personalized Medicine: The carotid artery shunt kit industry is witnessing a transition to personalized medicine, where therapy and devices are customized to the specific needs of individual patients. Personalized shunt kits, which are created to fit unique anatomical variations, are becoming more prevalent. These personalized solutions assist in better surgical outcomes by managing distinctive patient conditions as well as minimizing complications. This is complemented by developments in imaging technologies and patient-specific information, allowing medical professionals to make better decisions in the operating room and improve treatment plans.
• Regulatory Changes and Approvals: Regulatory changes are shaping the carotid artery shunt kit market. Tougher regulations in certain markets, including the United States and Europe, guarantee that only the safest and most efficient devices are licensed for use. Conversely, developing markets such as China and India are seeing quicker regulatory approvals, which is speeding up market development. With regulations changing, firms need to comply with global standards, fostering innovation and enhancing the quality and safety of carotid artery shunt kits overall.

These nascent trends-minimally invasive treatments, advances in technology, aging population, personalized care, and regulatory changes-are transforming the carotid artery shunt kit market. The market is more dynamic as continuous innovation continues to improve patient care, surgical results, and general market growth.

Recent Developments in the Carotid Artery Shunt Kit Market

Current trends in the carotid artery shunt kit market indicate increasing emphasis on enhancing the efficacy and safety of carotid artery procedures. Advances in technology and regulatory shifts are driving a wider use of advanced medical devices across different regions.

• Introduction of Advanced Shunt Kits: Recent developments have resulted in the creation of shunt kits with better materials and designs that minimize the risk of complications. The kits have improved blood flow regulation and are more resistant, which enhances surgical results and patient recovery periods. The use of bioresorbable materials and improved shunt structures has greatly minimized risks like infection and thromboembolic complications.
• Growth in Emerging Markets: The carotid artery shunt kit market is growing at a very fast rate in emerging countries like China and India. It is being spurred by enhanced healthcare expenditure and a growing prevalence of cardiovascular diseases. The firms are entering these nations with low-cost, high-performance devices intended to serve local markets. The growth in these nations is a large opportunity for producers to access a previously underserved patient population.
• Advanced Patient Monitoring Features: New carotid artery shunt kits increasingly include real-time monitoring technologies. These advances assist healthcare professionals to monitor blood circulation during the surgical procedure, ensuring fewer chances for complications and increasing the accuracy of surgery. Integrating sensors and other monitoring systems, these kits ensure that surgeons are able to make necessary adjustments in real-time during the process, thus boosting patient safety.
• Rise in Minimally Invasive Surgeries: There has been a significant rise in the use of minimally invasive carotid artery procedures, with the help of improved shunt kit technology. These procedures are linked to quicker recovery, reduced complications, and improved overall results. Consequently, there has been a rise in demand for shunt kits that enable these procedures, resulting in further product developments.
• Regulatory Changes and Approvals: Regulatory agencies across the globe are simplifying new carotid artery shunt kits' approval procedures. This change has accelerated the market launch of sophisticated products. Companies are collaborating very closely with regulatory agencies to comply with local regulations, resulting in accelerated market response and enhanced device safety.

Current trends in the carotid artery shunt kit industry show the concern of the industry to enhance safety, minimize complications, and broaden its reach into new geographic locations. These trends are revolutionizing the market and propelling growth, especially in developing economies and through technology advancements.

Strategic Growth Opportunities in the Carotid Artery Shunt Kit Market

The carotid artery shunt kit market is full of growth opportunities. By recognizing major applications and concentrating on emerging trends, companies can take advantage of the growing demand for efficient surgical solutions.

• Concentrate on Emerging Markets: Growth opportunities exist in emerging markets like China and India because they have growing healthcare infrastructures and increasing rates of cardiovascular diseases. Manufacturers can widen their presence by offering cheap, high-quality shunt kits suitable for these markets. Market growth will be fueled by the growing uptake of sophisticated medical technology in these countries.
• Focus on Minimally Invasive Solutions: Minimally invasive procedures are on the rise, with opportunities for expansion in the carotid artery shunt kit market. Businesses have the potential to design shunt kits specifically for these types of procedures, which come with the benefit of faster recovery and better patient outcomes. As the demand for minimally invasive technology rises, manufacturers need to concentrate on innovation in this area.
• Development of Personalized Medicine: As the demand for personalized medicine grows, there is potential for the creation of shunt kits designed to meet the individualized needs of patients. New technologies like 3D imaging and made-to-measure medical devices may be used to rectify unique anatomical issues and enhance surgical success. Firms that capitalize on this wave will most likely achieve a competitive edge over other companies.
• Collaboration with Healthcare Providers: Working with healthcare institutions, including surgical centers and hospitals, presents the potential to enhance the rate of uptake for carotid artery shunt kits. Collaborations aimed at training, research, and education can enhance the use of new shunt kits and promote effective application in clinics.
• Emphasis on Regulatory Approvals: Getting quicker regulatory approval and complying with global standards presents a considerable growth prospect. By being compliant with strict regulations in major markets like the U.S. and Europe, businesses can gain entry to a greater market and establish confidence with healthcare providers.

Strategic growth prospects in the carotid artery shunt kit market are centered around penetrating emerging markets, emphasizing minimally invasive solutions, individualizing medicine, partnering with healthcare providers, and traversing regulatory environments. By taking advantage of these opportunities, businesses can fuel growth and increase their market share.

Carotid Artery Shunt Kit Market Driver and Challenges

The carotid artery shunt kit market is affected by a number of drivers and challenges such as technological advances, economic pressures, and regulatory demands.

The factors responsible for driving the carotid artery shunt kit market include:

1. Technological Advancements: Technological innovation in medical equipment is a prime growth driver for the market. Advances in materials, including bioresorbable shunts and real-time monitoring, are enhancing outcomes during surgery and minimizing complications. Improved and simpler kits are enabling medical professionals to carry out carotid artery procedures with more accuracy.

2. Aging Population: The ageing population, especially in developed nations, is one of the major drivers for the carotid artery shunt kit market. Elderly people are at a higher risk of cardiovascular diseases, thus requiring more carotid artery surgeries. The rising population of older people is increasing the demand for sophisticated shunt kits to assist these procedures.

3. Increasing Prevalence of Cardiovascular Diseases: Growing occurrence of cardiovascular disease all over the globe is stimulating demand for carotid artery procedures and consequently, shunt kits. An upsurge in conditions such as atherosclerosis and stroke is emphasizing the need for safe surgical interventions. As the cardiovascular disease burden rises across the world, the demand for carotid artery shunt kits grows.

4. Increasing Investments in Healthcare: Growth in healthcare spending in both emerging and developed markets is boosting growth in the carotid artery shunt kit market. When governments are investing in the healthcare infrastructure, there is more focus on enhancing surgical interventions as well as care for patients. This brings forth the demand for cutting-edge medical technologies such as shunt kits.

5. Supportive Regulatory Framework: A positive regulatory framework in countries like the U.S. and Europe is helping to expedite the approval of new medical devices. Regulatory authorities are making efforts to simplify the approval process, which speeds up the release of new and enhanced shunt kits, fueling market growth.

Challenges in the carotid artery shunt kit market are:

1. High Cost of Advanced Devices: The exorbitant price of sophisticated carotid artery shunt kits is a hindrance to market expansion, especially in developing economies. Although the devices provide better results, their steep price restricts access for some patients, making it difficult to achieve widespread adoption. Companies need to prioritize balancing cost and innovation to address a wider patient population.

2. Shortage of Skilled Surgeons: The lack of well-trained surgeons familiar with newer shunt kits is a major challenge. Though newer technologies have made shunt kits easier to use, specialized training is still required to apply the devices. This constraint can hinder the implementation of new technologies, particularly in areas that have limited exposure to trained physicians.

3. Regulatory Barriers: Strict regulatory rules in certain markets can delay the process of approval for new carotid artery shunt kits. Firms have to penetrate difficult regulatory environments to comply and secure entry into a market. This can impede the launch of new products, thus affecting the prospect for growth in such markets.

The carotid artery shunt kit market is influenced by major drivers including technological innovation, aging population, high cardiovascular disease incidence, growing investments in healthcare, and a supportive regulatory landscape. High costs, unavailability of specialized surgeons, and regulatory obstacles are the challenges that need to be overcome to fully realize the market's potential. How these factors interact will dictate the direction of the market's growth.

List of Carotid Artery Shunt Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies carotid artery shunt kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the carotid artery shunt kit companies profiled in this report include-

• Cardinal Health
• LeMaitre
• McKesson Medical
• Edwards Lifesciences Corporation
• Axiom Medical Supplies

Carotid Artery Shunt Kit Market by Segment

The study includes a forecast for the global carotid artery shunt kit market by type, application, and region.

Carotid Artery Shunt Kit Market by Type [Value from 2019 to 2031]:

• Conventional Shunt
• Flow Reversal System

Carotid Artery Shunt Kit Market by Application [Value from 2019 to 2031]:

• Hospital
• Ambulatory Surgery Center
• Others

Carotid Artery Shunt Kit Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Carotid Artery Shunt Kit Market

The carotid artery shunt kit market indicate an increasing focus on improving medical procedures for carotid artery disease. Carotid artery shunting is crucial in avoiding complications like stroke in carotid endarterectomy procedures. carotid artery shunt kit market advancements are aimed at technological advancements, breakthroughs in medical devices, and improving awareness of the advantages of these procedures. The market for the kits is expanding in different geographic regions due to increasing aging population and rising occurrence of cardiovascular ailments. Major economies, including the United States, China, Germany, India, and Japan, are undergoing transformation in market forces.

• United States: Recent improvements in the market for the United States carotid artery shunt kit include increased precise and user-centric devices. These technologies are designed to enhance patient outcomes during procedures by minimizing complications and recovery periods. Also, some healthcare providers are implementing minimally invasive procedures, which have increased the demand for advanced shunt kits. Changes in regulations and an increase in the number of patients needing carotid artery surgery have also fueled market growth. The U.S. market is still a leader, fueled by technological innovation and a strong healthcare infrastructure.
• China: China has witnessed rising demand for the carotid artery shunt kit market, driven mainly by the rising incidence of cardiovascular diseases among its aging population. The nation is experiencing large-scale investments in healthcare infrastructure, which has led to the acceptance of sophisticated medical devices, such as carotid artery shunt kits. Chinese companies are focusing on enhancing the affordability and availability of these devices, making them accessible to a wider market. Additionally, China's regulatory framework is also changing, with the authorities giving quicker approvals to medical devices, which results in greater market expansion and competitiveness.
• Germany: The carotid artery shunt kit market in Germany is marked by intense technological advancement. German companies specialize in making some of the world's most cutting-edge and precise shunt kits, adhering to strict quality standards. The nation's healthcare system facilitates the large-scale use of such technologies, and there is an increasing focus on minimally invasive procedures. The growth of the market is also facilitated by a focus on early diagnosis and preventative care, resulting in more carotid artery surgeries. Additionally, the strong export potential of Germany has helped it become established in overseas markets.
• India: India's market for carotid artery shunt kits is growing on account of enhancement in healthcare facilities and rising incidences of cardiovascular diseases. The aging population coupled with increasing old-age dependency makes carotid artery surgery a necessary treatment requirement, hence triggering demand for shunt kits. The Indian market is also observing international players coming in and promoting new, value-for-money offerings. Yet, price sensitivity and access to trained health professionals pose the challenges, but the outlook is positive in the market as a result of increasing investments in the healthcare sector and awareness.
• Japan: Japan's carotid artery shunt kit market is favored by good quality healthcare services as well as developed technological infrastructure. The nation has experienced a trend towards more efficient and effective shunt kits favoring minimally invasive procedures. With the aging population of Japan, the demand for carotid artery procedures has increased, making the market grow. The government support for healthcare research and innovation has also enhanced the rate at which cutting-edge medical devices are developed. Japan remains a major global market player due to its established healthcare industry and innovation-led strategy.

Features of the Global Carotid Artery Shunt Kit Market

Market Size Estimates: Carotid artery shunt kit market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Carotid artery shunt kit market size by type, application, and region in terms of value ($B).

Regional Analysis: Carotid artery shunt kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the carotid artery shunt kit market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the carotid artery shunt kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the carotid artery shunt kit market by type (conventional shunt and flow reversal system), application (hospital, ambulatory surgery center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Carotid Artery Shunt Kit Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Carotid Artery Shunt Kit Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Carotid Artery Shunt Kit Market by Type
  • 3.3.1: Conventional Shunt
  • 3.3.2: Flow Reversal System
• 3.4: Global Carotid Artery Shunt Kit Market by Application
  • 3.4.1: Hospital
  • 3.4.2: Ambulatory Surgery Center
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Carotid Artery Shunt Kit Market by Region
• 4.2: North American Carotid Artery Shunt Kit Market
  • 4.2.1: North American Market by Type: Conventional Shunt and Flow Reversal System
  • 4.2.2: North American Market by Application: Hospital, Ambulatory Surgery Center, and Others
• 4.3: European Carotid Artery Shunt Kit Market
  • 4.3.1: European Market by Type: Conventional Shunt and Flow Reversal System
  • 4.3.2: European Market by Application: Hospital, Ambulatory Surgery Center, and Others
• 4.4: APAC Carotid Artery Shunt Kit Market
  • 4.4.1: APAC Market by Type: Conventional Shunt and Flow Reversal System
  • 4.4.2: APAC Market by Application: Hospital, Ambulatory Surgery Center, and Others
• 4.5: ROW Carotid Artery Shunt Kit Market
  • 4.5.1: ROW Market by Type: Conventional Shunt and Flow Reversal System
  • 4.5.2: ROW Market by Application: Hospital, Ambulatory Surgery Center, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Carotid Artery Shunt Kit Market by Type
  • 6.1.2: Growth Opportunities for the Global Carotid Artery Shunt Kit Market by Application
  • 6.1.3: Growth Opportunities for the Global Carotid Artery Shunt Kit Market by Region
• 6.2: Emerging Trends in the Global Carotid Artery Shunt Kit Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Carotid Artery Shunt Kit Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Carotid Artery Shunt Kit Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Cardinal Health
• 7.2: LeMaitre
• 7.3: McKesson Medical
• 7.4: Edwards Lifesciences Corporation
• 7.5: Axiom Medical Supplies